rs377502207
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3
The NM_000492.4(CFTR):c.2907A>C(p.Ala969=) variant causes a splice region, synonymous change. The variant allele was found at a frequency of 0.00000137 in 1,461,394 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 2/2 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. A969A) has been classified as Likely benign.
Frequency
Consequence
NM_000492.4 splice_region, synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CFTR | NM_000492.4 | c.2907A>C | p.Ala969= | splice_region_variant, synonymous_variant | 17/27 | ENST00000003084.11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CFTR | ENST00000003084.11 | c.2907A>C | p.Ala969= | splice_region_variant, synonymous_variant | 17/27 | 1 | NM_000492.4 | P2 |
Frequencies
GnomAD3 genomes ? Cov.: 33
GnomAD3 exomes AF: 0.0000239 AC: 6AN: 251120Hom.: 0 AF XY: 0.0000442 AC XY: 6AN XY: 135758
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461394Hom.: 0 Cov.: 32 AF XY: 0.00000138 AC XY: 1AN XY: 726996
GnomAD4 genome ? Cov.: 33
ClinVar
Submissions by phenotype
Cystic fibrosis Pathogenic:1Uncertain:2Benign:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Mar 07, 2019 | Variant summary: CFTR c.2907A>C (p.Ala969Ala) alters a conserved nucleotide located close to a canonical splice site and therefore could affect mRNA splicing, leading to a significantly altered protein sequence. Several computational tools predict a significant impact on normal splicing: one predicts the variant abolishes a 5' splicing donor site, two predict the variant weakens a 5' donor site. At least one publication reported experimental evidence that this variant affects mRNA splicing, demonstrating in a minigene assay that c.2907A>C led to skipping of exon 17, predicted to result in a frameshift and a premature stop codon (Tian 2016). The variant allele was found at a frequency of 2.4e-05 in 251120 control chromosomes, exclusively observed within the East Asian subpopulation (gnomAD). c.2907A>C has been reported in the literature in a compound heterozygote Chinese individual affected with Cystic Fibrosis (Tian 2016). A ClinVar submission from a clinical diagnostic laboratory (evaluation after 2014) cites the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as likely pathogenic. - |
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 15, 2014 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Counsyl | Apr 09, 2018 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Invitae | Nov 18, 2023 | This sequence change affects codon 969 of the CFTR mRNA. It is a 'silent' change, meaning that it does not change the encoded amino acid sequence of the CFTR protein. It affects a nucleotide within the consensus splice site. This variant is present in population databases (rs377502207, gnomAD 0.03%). This variant has been observed in individual(s) with congenital absence of vas deferens and/or cystic fibrosis who had a second CFTR variant (PMID: 27081564, 32777524). ClinVar contains an entry for this variant (Variation ID: 549917). Studies have shown that this variant alters mRNA splicing and is expected to lead to the loss of protein expression (PMID: 27081564). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
CFTR-related condition Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 20, 2023 | The CFTR c.2907A>C variant is not predicted to result in an amino acid change (p.=). This variant is predicted to weaken the spice donor site at the exon 17/intron 17 boundary based on available splicing prediction programs (Alamut Visual Plus v1.6.1) and a functional study showed that this variant leads to skipping of exon 17 (Tian et al. 2016. PubMed ID: 27081564). This variant was reported in the compound heterozygous state in an individual with Cystic Fibrosis (C8, Tian et al. 2016. PubMed ID: 27081564) and was reported in three alleles in a study of individuals with congenital absence of the vas deferens (Table 1, No 45, Luo et al. 2021. PubMed ID: 32777524). This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. This variant is reported in 0.033% of alleles in individuals of East Asian descent in gnomAD (http://gnomad.broadinstitute.org/variant/7-117243835-A-C) and has conflicting information regarding its pathogenicity in ClinVar, ranging from likely benign to uncertain significance to likely pathogenic (https://www.ncbi.nlm.nih.gov/clinvar/variation/549917/). Although we suspect that this variant may be pathogenic, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at